347740 — P&K Skin Research Center Co Cashflow Statement

0.000.00%

Last trade - 00:00

IndustrialsSpeculativeSmall CapHigh Flyer

Annual cashflow statement for P&K Skin Research Center Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	5,376	6,719	7,293	7,130	4,700
Depreciation
Non-Cash Items	597	721	-110	-829	-3,113
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-124	382	-746	-262	2,227
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	6,495	8,666	7,697	7,507	5,549
Capital Expenditures	-541	-1,055	-2,810	-1,356	-1,560
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-2,789	-36,357	-7,002	-2,964	2,532
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-3,330	-37,412	-9,812	-4,320	972
Financing Cash Flow Items	—	-1,111	—	—	149
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	2,988	24,204	-264	284	-1,706
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	6,152	-4,541	-2,379	3,471	4,815